Jan Skvarka - Insider Trading & Ownership

Entity
Individual
Location
C/O Trillium Therapeutics Inc., 2488 Dunwin Drive, Mississauga, Ontario, Canada
Summary
The estimated net worth of Jan Skvarka is at least $1.07M dollars as of June 21, 2024. Jan Skvarka is the Director of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $1.07M.
All Insider Reports
All Insider Reports

Ownership of Jan Skvarka

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZNTL Zentalis Pharmaceuticals, Inc. Director $1.07M Jun 21, 2024
GLUE Monte Rosa Therapeutics, Inc. Director Jun 12, 2024
TRIL Trillium Therapeutics Inc. President and CEO, Director Nov 17, 2021

Insider Transactions Reported by Jan Skvarka:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.